Liège, Belgium, 04 July 2018, 18:00 CEST – Regulated Information – Mithra Pharmaceuticals SA/NV (Euronext Brussels: MITRA) today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that it received a notification of transparency from Meusinvest SA, having its registered seat located at 4000 Liège, Rue Lambert Lombart 3, on 02 July 2018.
Share it
Latest news
Mithra reaches milestone in estetrol skin study
8 April 2024
Mithra updates on its ongoing monetization process
28 March 2024